nodes	percent_of_prediction	percent_of_DWPC	metapath
Didanosine—Serum amylase increased—Cisplatin—bone cancer	0.0996	0.105	CcSEcCtD
Didanosine—Neurological symptom—Cisplatin—bone cancer	0.0346	0.0365	CcSEcCtD
Didanosine—PNP—Daunorubicin—Epirubicin—bone cancer	0.0238	0.519	CbGdCrCtD
Didanosine—PNP—Daunorubicin—Doxorubicin—bone cancer	0.022	0.481	CbGdCrCtD
Didanosine—Lactic acidosis—Epirubicin—bone cancer	0.022	0.0232	CcSEcCtD
Didanosine—Amylase increased—Cisplatin—bone cancer	0.0219	0.0231	CcSEcCtD
Didanosine—Lactic acidosis—Doxorubicin—bone cancer	0.0203	0.0214	CcSEcCtD
Didanosine—Optic neuritis—Cisplatin—bone cancer	0.017	0.0179	CcSEcCtD
Didanosine—Retinal disorder—Methotrexate—bone cancer	0.0161	0.0169	CcSEcCtD
Didanosine—Hepatotoxicity—Cisplatin—bone cancer	0.0135	0.0143	CcSEcCtD
Didanosine—Leukoderma—Methotrexate—bone cancer	0.0135	0.0142	CcSEcCtD
Didanosine—Infection—Carboplatin—bone cancer	0.0126	0.0133	CcSEcCtD
Didanosine—Leukoderma—Epirubicin—bone cancer	0.0126	0.0133	CcSEcCtD
Didanosine—Liver injury—Cisplatin—bone cancer	0.0124	0.0131	CcSEcCtD
Didanosine—Nephropathy—Methotrexate—bone cancer	0.012	0.0127	CcSEcCtD
Didanosine—Leukoderma—Doxorubicin—bone cancer	0.0117	0.0123	CcSEcCtD
Didanosine—Hyperuricaemia—Cisplatin—bone cancer	0.0113	0.0119	CcSEcCtD
Didanosine—Pain—Carboplatin—bone cancer	0.0109	0.0115	CcSEcCtD
Didanosine—Blood uric acid increased—Cisplatin—bone cancer	0.0106	0.0112	CcSEcCtD
Didanosine—Hepatocellular injury—Cisplatin—bone cancer	0.0105	0.011	CcSEcCtD
Didanosine—Body temperature increased—Carboplatin—bone cancer	0.01	0.0106	CcSEcCtD
Didanosine—Neuropathy—Cisplatin—bone cancer	0.00981	0.0103	CcSEcCtD
Didanosine—Optic neuritis—Epirubicin—bone cancer	0.00872	0.0092	CcSEcCtD
Didanosine—Renal failure acute—Cisplatin—bone cancer	0.00822	0.00866	CcSEcCtD
Didanosine—Optic neuritis—Doxorubicin—bone cancer	0.00807	0.00851	CcSEcCtD
Didanosine—Anaphylactoid reaction—Cisplatin—bone cancer	0.00784	0.00826	CcSEcCtD
Didanosine—Hepatomegaly—Epirubicin—bone cancer	0.00758	0.00799	CcSEcCtD
Didanosine—Hepatotoxicity—Methotrexate—bone cancer	0.00743	0.00783	CcSEcCtD
Didanosine—Neuritis—Epirubicin—bone cancer	0.00719	0.00758	CcSEcCtD
Didanosine—Hepatomegaly—Doxorubicin—bone cancer	0.00702	0.00739	CcSEcCtD
Didanosine—Neuritis—Doxorubicin—bone cancer	0.00665	0.00701	CcSEcCtD
Didanosine—Pancreatitis—Cisplatin—bone cancer	0.00643	0.00678	CcSEcCtD
Didanosine—Blood disorder—Epirubicin—bone cancer	0.00643	0.00677	CcSEcCtD
Didanosine—Liver injury—Epirubicin—bone cancer	0.00638	0.00672	CcSEcCtD
Didanosine—Hyperuricaemia—Methotrexate—bone cancer	0.00618	0.00652	CcSEcCtD
Didanosine—Blood disorder—Doxorubicin—bone cancer	0.00595	0.00627	CcSEcCtD
Didanosine—Inflammation—Methotrexate—bone cancer	0.00591	0.00623	CcSEcCtD
Didanosine—Liver injury—Doxorubicin—bone cancer	0.0059	0.00622	CcSEcCtD
Didanosine—Blood uric acid increased—Methotrexate—bone cancer	0.00584	0.00616	CcSEcCtD
Didanosine—Hyperuricaemia—Epirubicin—bone cancer	0.00579	0.0061	CcSEcCtD
Didanosine—Neuropathy peripheral—Cisplatin—bone cancer	0.00573	0.00604	CcSEcCtD
Didanosine—Inflammation—Epirubicin—bone cancer	0.00553	0.00583	CcSEcCtD
Didanosine—Hepatobiliary disease—Cisplatin—bone cancer	0.00553	0.00583	CcSEcCtD
Didanosine—Blood uric acid increased—Epirubicin—bone cancer	0.00547	0.00576	CcSEcCtD
Didanosine—Zalcitabine—CYP3A4—bone cancer	0.00539	1	CrCbGaD
Didanosine—Hepatocellular injury—Epirubicin—bone cancer	0.00537	0.00566	CcSEcCtD
Didanosine—Hyperuricaemia—Doxorubicin—bone cancer	0.00535	0.00564	CcSEcCtD
Didanosine—Inflammation—Doxorubicin—bone cancer	0.00512	0.0054	CcSEcCtD
Didanosine—Blood uric acid increased—Doxorubicin—bone cancer	0.00506	0.00533	CcSEcCtD
Didanosine—Neuropathy—Epirubicin—bone cancer	0.00504	0.00531	CcSEcCtD
Didanosine—Hepatocellular injury—Doxorubicin—bone cancer	0.00497	0.00523	CcSEcCtD
Didanosine—Dry eye—Epirubicin—bone cancer	0.00496	0.00522	CcSEcCtD
Didanosine—Diabetes mellitus—Methotrexate—bone cancer	0.00479	0.00504	CcSEcCtD
Didanosine—Neuropathy—Doxorubicin—bone cancer	0.00466	0.00491	CcSEcCtD
Didanosine—Alopecia—Cisplatin—bone cancer	0.00464	0.00489	CcSEcCtD
Didanosine—Hepatic failure—Methotrexate—bone cancer	0.00463	0.00488	CcSEcCtD
Didanosine—Dry eye—Doxorubicin—bone cancer	0.00459	0.00483	CcSEcCtD
Didanosine—Renal failure acute—Methotrexate—bone cancer	0.00451	0.00475	CcSEcCtD
Didanosine—Flatulence—Cisplatin—bone cancer	0.0045	0.00474	CcSEcCtD
Didanosine—Blood alkaline phosphatase increased—Epirubicin—bone cancer	0.00448	0.00472	CcSEcCtD
Didanosine—Diabetes mellitus—Epirubicin—bone cancer	0.00448	0.00472	CcSEcCtD
Didanosine—Hepatic function abnormal—Epirubicin—bone cancer	0.00446	0.0047	CcSEcCtD
Didanosine—Hepatic failure—Epirubicin—bone cancer	0.00433	0.00457	CcSEcCtD
Didanosine—Anaphylactoid reaction—Methotrexate—bone cancer	0.0043	0.00453	CcSEcCtD
Didanosine—Anaemia—Cisplatin—bone cancer	0.00422	0.00445	CcSEcCtD
Didanosine—Renal failure acute—Epirubicin—bone cancer	0.00422	0.00445	CcSEcCtD
Didanosine—Blood alkaline phosphatase increased—Doxorubicin—bone cancer	0.00414	0.00437	CcSEcCtD
Didanosine—Diabetes mellitus—Doxorubicin—bone cancer	0.00414	0.00437	CcSEcCtD
Didanosine—Hepatic function abnormal—Doxorubicin—bone cancer	0.00412	0.00435	CcSEcCtD
Didanosine—Malaise—Cisplatin—bone cancer	0.00412	0.00434	CcSEcCtD
Didanosine—Renal impairment—Epirubicin—bone cancer	0.00409	0.00431	CcSEcCtD
Didanosine—Leukopenia—Cisplatin—bone cancer	0.00409	0.00431	CcSEcCtD
Didanosine—Anaphylactoid reaction—Epirubicin—bone cancer	0.00403	0.00424	CcSEcCtD
Didanosine—Hepatic failure—Doxorubicin—bone cancer	0.00401	0.00423	CcSEcCtD
Didanosine—Hypoglycaemia—Epirubicin—bone cancer	0.00399	0.00421	CcSEcCtD
Didanosine—Renal failure acute—Doxorubicin—bone cancer	0.0039	0.00412	CcSEcCtD
Didanosine—Myalgia—Cisplatin—bone cancer	0.00389	0.0041	CcSEcCtD
Didanosine—Discomfort—Cisplatin—bone cancer	0.00384	0.00405	CcSEcCtD
Didanosine—Renal impairment—Doxorubicin—bone cancer	0.00379	0.00399	CcSEcCtD
Didanosine—Anaphylactic shock—Cisplatin—bone cancer	0.00373	0.00393	CcSEcCtD
Didanosine—Anaphylactoid reaction—Doxorubicin—bone cancer	0.00372	0.00393	CcSEcCtD
Didanosine—Infection—Cisplatin—bone cancer	0.0037	0.0039	CcSEcCtD
Didanosine—Hypoglycaemia—Doxorubicin—bone cancer	0.00369	0.00389	CcSEcCtD
Didanosine—Thrombocytopenia—Cisplatin—bone cancer	0.00365	0.00385	CcSEcCtD
Didanosine—Abdominal pain upper—Epirubicin—bone cancer	0.00356	0.00375	CcSEcCtD
Didanosine—Anorexia—Cisplatin—bone cancer	0.00355	0.00375	CcSEcCtD
Didanosine—Pancreatitis—Methotrexate—bone cancer	0.00353	0.00372	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Cisplatin—bone cancer	0.0034	0.00358	CcSEcCtD
Didanosine—Paraesthesia—Cisplatin—bone cancer	0.00335	0.00353	CcSEcCtD
Didanosine—Pancreatitis—Epirubicin—bone cancer	0.0033	0.00348	CcSEcCtD
Didanosine—Abdominal pain upper—Doxorubicin—bone cancer	0.00329	0.00347	CcSEcCtD
Didanosine—Decreased appetite—Cisplatin—bone cancer	0.00324	0.00342	CcSEcCtD
Didanosine—Pain—Cisplatin—bone cancer	0.00319	0.00336	CcSEcCtD
Didanosine—Pancreatitis—Doxorubicin—bone cancer	0.00305	0.00322	CcSEcCtD
Didanosine—Hyperglycaemia—Epirubicin—bone cancer	0.00304	0.0032	CcSEcCtD
Didanosine—Hepatobiliary disease—Methotrexate—bone cancer	0.00303	0.0032	CcSEcCtD
Didanosine—Agranulocytosis—Methotrexate—bone cancer	0.00299	0.00316	CcSEcCtD
Didanosine—Body temperature increased—Cisplatin—bone cancer	0.00295	0.00311	CcSEcCtD
Didanosine—Neuropathy peripheral—Epirubicin—bone cancer	0.00294	0.0031	CcSEcCtD
Didanosine—Hepatitis—Methotrexate—bone cancer	0.00288	0.00304	CcSEcCtD
Didanosine—Hepatobiliary disease—Epirubicin—bone cancer	0.00284	0.00299	CcSEcCtD
Didanosine—Hyperglycaemia—Doxorubicin—bone cancer	0.00281	0.00296	CcSEcCtD
Didanosine—Agranulocytosis—Epirubicin—bone cancer	0.0028	0.00295	CcSEcCtD
Didanosine—Hypersensitivity—Cisplatin—bone cancer	0.00275	0.0029	CcSEcCtD
Didanosine—Neuropathy peripheral—Doxorubicin—bone cancer	0.00272	0.00287	CcSEcCtD
Didanosine—Hepatitis—Epirubicin—bone cancer	0.0027	0.00284	CcSEcCtD
Didanosine—Hypoaesthesia—Epirubicin—bone cancer	0.00268	0.00283	CcSEcCtD
Didanosine—Asthenia—Cisplatin—bone cancer	0.00268	0.00282	CcSEcCtD
Didanosine—Hepatobiliary disease—Doxorubicin—bone cancer	0.00263	0.00277	CcSEcCtD
Didanosine—Agranulocytosis—Doxorubicin—bone cancer	0.00259	0.00273	CcSEcCtD
Didanosine—Chills—Methotrexate—bone cancer	0.00258	0.00272	CcSEcCtD
Didanosine—Diarrhoea—Cisplatin—bone cancer	0.00255	0.00269	CcSEcCtD
Didanosine—Alopecia—Methotrexate—bone cancer	0.00254	0.00268	CcSEcCtD
Didanosine—Hepatitis—Doxorubicin—bone cancer	0.00249	0.00263	CcSEcCtD
Didanosine—Hypoaesthesia—Doxorubicin—bone cancer	0.00248	0.00262	CcSEcCtD
Didanosine—Chills—Epirubicin—bone cancer	0.00242	0.00255	CcSEcCtD
Didanosine—Alopecia—Epirubicin—bone cancer	0.00238	0.00251	CcSEcCtD
Didanosine—Vomiting—Cisplatin—bone cancer	0.00237	0.0025	CcSEcCtD
Didanosine—Rash—Cisplatin—bone cancer	0.00235	0.00248	CcSEcCtD
Didanosine—Dermatitis—Cisplatin—bone cancer	0.00235	0.00248	CcSEcCtD
Didanosine—Anaemia—Methotrexate—bone cancer	0.00232	0.00244	CcSEcCtD
Didanosine—Flatulence—Epirubicin—bone cancer	0.00231	0.00244	CcSEcCtD
Didanosine—Malaise—Methotrexate—bone cancer	0.00226	0.00238	CcSEcCtD
Didanosine—Leukopenia—Methotrexate—bone cancer	0.00224	0.00237	CcSEcCtD
Didanosine—Chills—Doxorubicin—bone cancer	0.00224	0.00236	CcSEcCtD
Didanosine—Nausea—Cisplatin—bone cancer	0.00221	0.00233	CcSEcCtD
Didanosine—Alopecia—Doxorubicin—bone cancer	0.0022	0.00232	CcSEcCtD
Didanosine—Anaemia—Epirubicin—bone cancer	0.00217	0.00229	CcSEcCtD
Didanosine—Flatulence—Doxorubicin—bone cancer	0.00214	0.00225	CcSEcCtD
Didanosine—Myalgia—Methotrexate—bone cancer	0.00213	0.00225	CcSEcCtD
Didanosine—Arthralgia—Methotrexate—bone cancer	0.00213	0.00225	CcSEcCtD
Didanosine—Malaise—Epirubicin—bone cancer	0.00212	0.00223	CcSEcCtD
Didanosine—Discomfort—Methotrexate—bone cancer	0.00211	0.00222	CcSEcCtD
Didanosine—Leukopenia—Epirubicin—bone cancer	0.0021	0.00221	CcSEcCtD
Didanosine—Anaphylactic shock—Methotrexate—bone cancer	0.00205	0.00216	CcSEcCtD
Didanosine—Infection—Methotrexate—bone cancer	0.00203	0.00214	CcSEcCtD
Didanosine—Anaemia—Doxorubicin—bone cancer	0.00201	0.00211	CcSEcCtD
Didanosine—Thrombocytopenia—Methotrexate—bone cancer	0.002	0.00211	CcSEcCtD
Didanosine—Myalgia—Epirubicin—bone cancer	0.002	0.00211	CcSEcCtD
Didanosine—Arthralgia—Epirubicin—bone cancer	0.002	0.00211	CcSEcCtD
Didanosine—Discomfort—Epirubicin—bone cancer	0.00197	0.00208	CcSEcCtD
Didanosine—Malaise—Doxorubicin—bone cancer	0.00196	0.00206	CcSEcCtD
Didanosine—Dry mouth—Epirubicin—bone cancer	0.00195	0.00206	CcSEcCtD
Didanosine—Anorexia—Methotrexate—bone cancer	0.00195	0.00206	CcSEcCtD
Didanosine—Leukopenia—Doxorubicin—bone cancer	0.00194	0.00205	CcSEcCtD
Didanosine—Anaphylactic shock—Epirubicin—bone cancer	0.00191	0.00202	CcSEcCtD
Didanosine—Infection—Epirubicin—bone cancer	0.0019	0.002	CcSEcCtD
Didanosine—Thrombocytopenia—Epirubicin—bone cancer	0.00187	0.00198	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Methotrexate—bone cancer	0.00186	0.00196	CcSEcCtD
Didanosine—Arthralgia—Doxorubicin—bone cancer	0.00185	0.00195	CcSEcCtD
Didanosine—Myalgia—Doxorubicin—bone cancer	0.00185	0.00195	CcSEcCtD
Didanosine—Paraesthesia—Methotrexate—bone cancer	0.00184	0.00194	CcSEcCtD
Didanosine—Discomfort—Doxorubicin—bone cancer	0.00183	0.00192	CcSEcCtD
Didanosine—Anorexia—Epirubicin—bone cancer	0.00183	0.00192	CcSEcCtD
Didanosine—Dry mouth—Doxorubicin—bone cancer	0.00181	0.00191	CcSEcCtD
Didanosine—Dyspepsia—Methotrexate—bone cancer	0.0018	0.0019	CcSEcCtD
Didanosine—Decreased appetite—Methotrexate—bone cancer	0.00178	0.00187	CcSEcCtD
Didanosine—Anaphylactic shock—Doxorubicin—bone cancer	0.00177	0.00187	CcSEcCtD
Didanosine—Infection—Doxorubicin—bone cancer	0.00176	0.00186	CcSEcCtD
Didanosine—Pain—Methotrexate—bone cancer	0.00175	0.00184	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Epirubicin—bone cancer	0.00174	0.00184	CcSEcCtD
Didanosine—Thrombocytopenia—Doxorubicin—bone cancer	0.00173	0.00183	CcSEcCtD
Didanosine—Paraesthesia—Epirubicin—bone cancer	0.00172	0.00181	CcSEcCtD
Didanosine—Anorexia—Doxorubicin—bone cancer	0.00169	0.00178	CcSEcCtD
Didanosine—Dyspepsia—Epirubicin—bone cancer	0.00169	0.00178	CcSEcCtD
Didanosine—Gastrointestinal pain—Methotrexate—bone cancer	0.00167	0.00176	CcSEcCtD
Didanosine—Decreased appetite—Epirubicin—bone cancer	0.00166	0.00175	CcSEcCtD
Didanosine—Pain—Epirubicin—bone cancer	0.00164	0.00173	CcSEcCtD
Didanosine—Abdominal pain—Methotrexate—bone cancer	0.00162	0.0017	CcSEcCtD
Didanosine—Body temperature increased—Methotrexate—bone cancer	0.00162	0.0017	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.00161	0.0017	CcSEcCtD
Didanosine—Paraesthesia—Doxorubicin—bone cancer	0.00159	0.00168	CcSEcCtD
Didanosine—Gastrointestinal pain—Epirubicin—bone cancer	0.00157	0.00165	CcSEcCtD
Didanosine—Dyspepsia—Doxorubicin—bone cancer	0.00156	0.00164	CcSEcCtD
Didanosine—Decreased appetite—Doxorubicin—bone cancer	0.00154	0.00162	CcSEcCtD
Didanosine—Pain—Doxorubicin—bone cancer	0.00152	0.0016	CcSEcCtD
Didanosine—Abdominal pain—Epirubicin—bone cancer	0.00151	0.0016	CcSEcCtD
Didanosine—Body temperature increased—Epirubicin—bone cancer	0.00151	0.0016	CcSEcCtD
Didanosine—Hypersensitivity—Methotrexate—bone cancer	0.00151	0.00159	CcSEcCtD
Didanosine—Asthenia—Methotrexate—bone cancer	0.00147	0.00155	CcSEcCtD
Didanosine—Gastrointestinal pain—Doxorubicin—bone cancer	0.00145	0.00153	CcSEcCtD
Didanosine—Pruritus—Methotrexate—bone cancer	0.00145	0.00153	CcSEcCtD
Didanosine—Hypersensitivity—Epirubicin—bone cancer	0.00141	0.00149	CcSEcCtD
Didanosine—Abdominal pain—Doxorubicin—bone cancer	0.0014	0.00148	CcSEcCtD
Didanosine—Body temperature increased—Doxorubicin—bone cancer	0.0014	0.00148	CcSEcCtD
Didanosine—Diarrhoea—Methotrexate—bone cancer	0.0014	0.00148	CcSEcCtD
Didanosine—Asthenia—Epirubicin—bone cancer	0.00137	0.00145	CcSEcCtD
Didanosine—Pruritus—Epirubicin—bone cancer	0.00135	0.00143	CcSEcCtD
Didanosine—Diarrhoea—Epirubicin—bone cancer	0.00131	0.00138	CcSEcCtD
Didanosine—Hypersensitivity—Doxorubicin—bone cancer	0.00131	0.00138	CcSEcCtD
Didanosine—Vomiting—Methotrexate—bone cancer	0.0013	0.00137	CcSEcCtD
Didanosine—Rash—Methotrexate—bone cancer	0.00129	0.00136	CcSEcCtD
Didanosine—Dermatitis—Methotrexate—bone cancer	0.00129	0.00136	CcSEcCtD
Didanosine—Headache—Methotrexate—bone cancer	0.00128	0.00135	CcSEcCtD
Didanosine—Asthenia—Doxorubicin—bone cancer	0.00127	0.00134	CcSEcCtD
Didanosine—Pruritus—Doxorubicin—bone cancer	0.00125	0.00132	CcSEcCtD
Didanosine—Vomiting—Epirubicin—bone cancer	0.00122	0.00128	CcSEcCtD
Didanosine—Nausea—Methotrexate—bone cancer	0.00122	0.00128	CcSEcCtD
Didanosine—Diarrhoea—Doxorubicin—bone cancer	0.00121	0.00128	CcSEcCtD
Didanosine—Rash—Epirubicin—bone cancer	0.00121	0.00127	CcSEcCtD
Didanosine—Dermatitis—Epirubicin—bone cancer	0.00121	0.00127	CcSEcCtD
Didanosine—Headache—Epirubicin—bone cancer	0.0012	0.00126	CcSEcCtD
Didanosine—Nausea—Epirubicin—bone cancer	0.00114	0.0012	CcSEcCtD
Didanosine—Vomiting—Doxorubicin—bone cancer	0.00113	0.00119	CcSEcCtD
Didanosine—Rash—Doxorubicin—bone cancer	0.00112	0.00118	CcSEcCtD
Didanosine—Dermatitis—Doxorubicin—bone cancer	0.00112	0.00118	CcSEcCtD
Didanosine—Headache—Doxorubicin—bone cancer	0.00111	0.00117	CcSEcCtD
Didanosine—Nausea—Doxorubicin—bone cancer	0.00105	0.00111	CcSEcCtD
